Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
Article in European Journal of Clinical Pharmacology (February 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in European Journal of Clinical Pharmacology (February 2024)
Preprint in Research Square (September 2023)
Article in Diagnostics (July 2023)